Centessa Pharmaceuticals plc
CNTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$54,891 | -$50,343 | -$26,135 | -$111,329 |
| Dep. & Amort. | $237 | $226 | $217 | $228 |
| Deferred Tax | $255 | $1,026 | $995 | $389 |
| Stock-Based Comp. | $7,194 | $7,949 | $7,883 | $8,328 |
| Change in WC | -$11,264 | $18,553 | -$38,539 | $25,199 |
| Other Non-Cash | $157 | $137 | -$1,667 | $34,385 |
| Operating Cash Flow | -$58,312 | -$22,452 | -$57,246 | -$42,800 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$234 | -$126 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$45,512 | -$83,061 | -$222,388 | $573 |
| Inv. Sales/Matur. | $107,691 | $43,233 | $75,088 | $24,412 |
| Other Inv. Act. | $0 | $0 | -$75,088 | $15 |
| Investing Cash Flow | $61,945 | -$39,954 | -$222,388 | $25,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$762 |
| Stock Issued | $0 | $1,757 | $7,902 | -$30 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,437 | -$152 | -$4,816 | $3,755 |
| Financing Cash Flow | $3,437 | $1,605 | $3,086 | $2,963 |
| Forex Effect | -$501 | -$113 | -$1,517 | $3,032 |
| Net Chg. in Cash | $6,569 | -$60,914 | -$278,065 | -$11,805 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,242 | $105,156 | $383,221 | $395,026 |
| End Cash | $50,811 | $44,242 | $105,156 | $383,221 |
| Free Cash Flow | -$58,546 | -$22,578 | -$57,246 | -$42,800 |